In8bio annual depreciation and amortization
2020
2021
2022
2023
2024
2025
In8bio Depreciation & Amortization Growth & History (INAB)
In8bio's depreciation and amortization was $1.8M for fiscal 2025.
View full In8bio company overviewIn8bio annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.8M | −$64,000 | −3.49% |
| 2024 | 2024-12-31 | $1.8M | $2,000 | +0.11% |
| 2023 | 2023-12-31 | $1.8M | $1.2M | +201.48% |
| 2022 | 2022-12-31 | $608,000 | −$18,000 | −2.88% |
| 2021 | 2021-12-31 | $626,000 | $538,000 | +611.36% |
| 2020 | 2020-12-31 | $88,000 | — | — |
In8bio quarterly depreciation and amortization
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $362,000 | −$224,000 | −38.23% |
| Q1 2026 | 2026-03-31 | $353,000 | −$143,000 | −28.83% |
| Q4 2025 | 2025-12-31 | $521,000 | — | — |
| Q3 2025 | 2025-09-30 | $326,000 | −$202,000 | −38.26% |
| Q2 2025 | 2025-06-30 | $586,000 | $193,000 | +49.11% |
| Q1 2025 | 2025-03-31 | $496,000 | $53,000 | +11.96% |
| Q3 2024 | 2024-09-30 | $528,000 | −$10,000 | −1.86% |
| Q2 2024 | 2024-06-30 | $393,000 | −$37,000 | −8.60% |
| Q1 2024 | 2024-03-31 | $443,000 | $12,000 | +2.78% |
| Q3 2023 | 2023-09-30 | $538,000 | $415,000 | +337.40% |
| Q2 2023 | 2023-06-30 | $430,000 | $306,000 | +246.77% |
| Q1 2023 | 2023-03-31 | $431,000 | $266,000 | +161.21% |
| Q3 2022 | 2022-09-30 | $123,000 | −$40,000 | −24.54% |
| Q2 2022 | 2022-06-30 | $124,000 | −$36,000 | −22.50% |
| Q1 2022 | 2022-03-31 | $165,000 | $30,000 | +22.22% |
| Q3 2021 | 2021-09-30 | $163,000 | $141,000 | +640.91% |
| Q2 2021 | 2021-06-30 | $160,000 | $138,000 | +627.27% |
| Q1 2021 | 2021-03-31 | $135,000 | — | — |
| Q3 2020 | 2020-09-30 | $22,000 | — | — |
| Q2 2020 | 2020-06-30 | $22,000 | — | — |
In8bio depreciation and amortization trends
Over the last five fiscal years, In8bio's depreciation and amortization increased from $88,000 to $1.8M, a change of $1.7M. The latest reported quarter, Q2 2026, shows $362,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review In8bio source filings ↗